Alzheimer’s diagnosis revamp embraces rating scale similar to cancer
By Julie Steenhuysen (Reuters) -Alzheimer’s disease experts are revamping the way doctors diagnose patients with the progressive brain disorder –…
Health
She’s 47, anorexic and wants help dying. Canada will soon allow it
By Anna Mehler Paperny TORONTO (Reuters) – Lisa Pauli wants to die. The 47-year-old has wrestled with the eating disorder…
US judge lets Kentucky enforce ban on transgender youth care for now
By Brendan Pierson (Reuters) – A federal judge in Kentucky ruled Friday that the state can enforce its law banning…
Brazilian school awarded UNESCO stamp for efforts to protect the ocean
By Sergio Queiroz RIO DE JANEIRO/BRASILIA (Reuters) – A group of Brazilian school children gleefully remove pieces of plastic and…
Exclusive-MoonLake Immunotherapeutics explores sale-sources
By David Carnevali (Reuters) -MoonLake Immunotherapeutics, a developer of an antibody-derived treatment for inflammatory skin conditions, is exploring a sale,…
Factbox-Hottest spots in U.S. as heat wave blankets Southwest
(Reuters) – More than 100 million Americans are facing a prolonged spell of sweltering weather into next week, with the…
Factbox-Food and beverage products that mention aspartame on their labels
(Reuters) – Aspartame, one of the world’s most popular sweeteners, has been deemed a “possible carcinogen” by two groups linked…
UnitedHealth’s lower-than-feared costs lift profit, shares
By Bhanvi Satija and Raghav Mahobe (Reuters) -UnitedHealth Group’s quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected…
WHO cancer arm deems aspartame ‘possible carcinogen’; consumption limits unchanged
By Jennifer Rigby LONDON (Reuters) -The sweetener aspartame is a “possible carcinogen” but it remains safe to consume at already-agreed…
Eli Lilly to buy Versanis for up to $1.93 billion in obesity drugs push
By Sriparna Roy (Reuters) -Eli Lilly and Co said on Friday it will buy privately held Versanis for potentially up…